Guangyao Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Guangyao Liu has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Jianxun Ding
Chinese Academy of Sciences
5 shared publications Xukai Wang
Department of Thoracic Surgery, China-Japan Union Hospital of Jilin University, Changchun, China
5 shared publicationsTongtong Zhu
Department of Traumatic Orthopedics, China-Japan Union Hospital of Jilin University, Changchun, China
4 shared publicationsMingran Zhang
Department of Orthopedics, China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Changchun 130033, PR China
3 shared publicationsHang Dong
Department of Traumatic Orthopedics, China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Changchun, 130033, PR China
2 shared publicationsLiguo Cui
Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, 5625 Renmin Street, Changchun 130022, PR China
2 shared publications
Latest Publications
- 12 December 2025
- Published by Elsevier in Biomaterials
- Vol. 329, 123921
Bone microenvironments-regulated biomaterials boost osteonecrosis therapy
- 12 December 2025
- Published by Elsevier in Biomaterials
- Vol. 329, 123921
Bone microenvironments-regulated biomaterials boost osteonecrosis therapy
- Open Access
- 31 October 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1702219
Decoding the immune microenvironment in osteosarcoma: new insights into checkpoints, vaccines, and CAR-T cells
Osteosarcoma (OS), the most prevalent primary malignant bone tumor, disproportionately affects adolescents and is marked by rapid progression and a high rate of pulmonary metastasis. Despite advances in multimodal treatment, outcomes remain dismal for metastatic or relapsed disease, largely due to chemoresistance, immune evasion, and the heterogeneous tumor microenvironment (TME). Increasing evidence underscores the immunoregulatory complexity of osteosarcoma, characterized by immunosuppressive myeloid-derived populations, dysfunctional lymphocyte infiltration, and exosome-mediated immune escape. While immune checkpoint inhibitors have revolutionized treatment in several malignancies, their impact in osteosarcoma remains modest, highlighting the need for combinatorial strategies. Emerging approaches such as adoptive T cell therapies, tumor vaccines, and CAR-T cell interventions are being explored to overcome the “cold” immune milieu. Furthermore, single-cell transcriptomics has shed light on cellular interactions within the osteosarcoma TME, offering insights into resistance mechanisms and potential biomarkers. This review provides a comprehensive overview of the immunological landscape of osteosarcoma and highlights current and emerging immunotherapeutic strategies aimed at improving clinical outcomes in this challenging malignancy.
- 31 October 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1702219
Open AccessDecoding the immune microenvironment in osteosarcoma: new insights into checkpoints, vaccines, and CAR-T cells
Osteosarcoma (OS), the most prevalent primary malignant bone tumor, disproportionately affects adolescents and is marked by rapid progression and a high rate of pulmonary metastasis. Despite advances in multimodal treatment, outcomes remain dismal for metastatic or relapsed disease, largely due to chemoresistance, immune evasion, and the heterogeneous tumor microenvironment (TME). Increasing evidence underscores the immunoregulatory complexity of osteosarcoma, characterized by immunosuppressive myeloid-derived populations, dysfunctional lymphocyte infiltration, and exosome-mediated immune escape. While immune checkpoint inhibitors have revolutionized treatment in several malignancies, their impact in osteosarcoma remains modest, highlighting the need for combinatorial strategies. Emerging approaches such as adoptive T cell therapies, tumor vaccines, and CAR-T cell interventions are being explored to overcome the “cold” immune milieu. Furthermore, single-cell transcriptomics has shed light on cellular interactions within the osteosarcoma TME, offering insights into resistance mechanisms and potential biomarkers. This review provides a comprehensive overview of the immunological landscape of osteosarcoma and highlights current and emerging immunotherapeutic strategies aimed at improving clinical outcomes in this challenging malignancy.
- Open Access
- 29 September 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1682794
Case Report: Novel mutation in CHD4 triggers occult breast cancer with bone metastases
Chromatin domain-binding protein 4 (CHD4), the ATPase core component of the NuRD complex, exerts dual roles in epigenetic regulation—mediating both gene silencing and activation. We report a case of occult breast cancer with extensive bone metastasis harboring a novel somatic truncation mutation in the catalytic SNF2 domain (CHD4 p.Trp736Ter). This mutation, unreported in other cancers to date, abolishes ATPase activity and disrupts NuRD complex assembly. Multimodal analysis (PET/CT, biomarkers, pathology) confirmed the case as luminal-A subtype and revealed a significant response to endocrine therapy. We hypothesize that this CHD4 mutation may alter the protein’s dual regulatory balance, particularly enhancing its potential gene-activating functions, and propose that impaired chromatin remodeling driven by such mutations is associated with metastatic progression of breast cancer.
- 29 September 2025
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1682794
Open AccessCase Report: Novel mutation in CHD4 triggers occult breast cancer with bone metastases
Chromatin domain-binding protein 4 (CHD4), the ATPase core component of the NuRD complex, exerts dual roles in epigenetic regulation—mediating both gene silencing and activation. We report a case of occult breast cancer with extensive bone metastasis harboring a novel somatic truncation mutation in the catalytic SNF2 domain (CHD4 p.Trp736Ter). This mutation, unreported in other cancers to date, abolishes ATPase activity and disrupts NuRD complex assembly. Multimodal analysis (PET/CT, biomarkers, pathology) confirmed the case as luminal-A subtype and revealed a significant response to endocrine therapy. We hypothesize that this CHD4 mutation may alter the protein’s dual regulatory balance, particularly enhancing its potential gene-activating functions, and propose that impaired chromatin remodeling driven by such mutations is associated with metastatic progression of breast cancer.
- 12 September 2025
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 147, 110111
Urolithin A protects mice against osteoarthritis by inhibiting chondrocyte ferroptosis through activating AMPK/mTOR/HIF-1α signaling pathway
- 12 September 2025
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 147, 110111
Urolithin A protects mice against osteoarthritis by inhibiting chondrocyte ferroptosis through activating AMPK/mTOR/HIF-1α signaling pathway
- Open Access
- 15 November 2024
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 19 (1) , 1-8
Experimental study of fractures of the posterior pelvic ring C1.1 using LC-II screws and internal fixation by plate
To compare the biomechanical outcomes of C1.1 posterior pelvic ring fractures treated with different numbers of LC-II screws and plate internal fixation. Nine adult preserved pelvic specimens were used. After being measured by bone densitometry, the specimens were randomly divided into 3 groups of 3 pelvic specimens each. The C1.1 pelvic fractures were generated by iliac osteotomies and anterior pelvic ring osteotomies. The fractures were fixed and randomly divided into three groups: (1) one LC-II screw, (2) two LC-II screws, and (3) two reconstruction plates. The anterior pelvic rings were all fixed with pubic branch screws. A biomechanical testing machine loaded all specimens vertically, recording the displacement and ultimate load of the specimens to quantify the stiffness. When loads up to 1000 N were applied, the displacement of the iliac bone was close between the one LC-II screw and the two LC-II screw group specimens; (P > 0.05); when loads such as 1000 N, 1200 N and 1400 N were applied, there was no significant difference in displacement between the plate fixation group and the two LC-II screw fixation group (P > 0.05), both of which were superior to the one LC-II screw fixation group (P < 0.05). There was no significant difference in compressive stiffness between the two LC-II screw fixation groups and the plate fixation group (P > 0.05), and both were superior to the one LC-II screw fixation group (P < 0.05) the ultimate load of both the two LC-II screws and the steel plate is greater than that of one LC-II screw (1.74 times the ultimate load of one LC-II screw for the two LC-II screws and 1.83 times the ultimate load of one LC-II screw for the steel plate). For posterior pelvic ring fractures of type C1.1, placement of two LC-II screws provides comparable posterior pelvic ring stability compared to reconstructed plates. At loads below 1000 N, one LC-II screw fixation and two LC-II screws were comparable in restoring posterior pelvic ring stability.
- 15 November 2024
- Published by Springer Nature in Journal of Orthopaedic Surgery and Research
- Vol. 19 (1) , 1-8
Open AccessExperimental study of fractures of the posterior pelvic ring C1.1 using LC-II screws and internal fixation by plate
To compare the biomechanical outcomes of C1.1 posterior pelvic ring fractures treated with different numbers of LC-II screws and plate internal fixation. Nine adult preserved pelvic specimens were used. After being measured by bone densitometry, the specimens were randomly divided into 3 groups of 3 pelvic specimens each. The C1.1 pelvic fractures were generated by iliac osteotomies and anterior pelvic ring osteotomies. The fractures were fixed and randomly divided into three groups: (1) one LC-II screw, (2) two LC-II screws, and (3) two reconstruction plates. The anterior pelvic rings were all fixed with pubic branch screws. A biomechanical testing machine loaded all specimens vertically, recording the displacement and ultimate load of the specimens to quantify the stiffness. When loads up to 1000 N were applied, the displacement of the iliac bone was close between the one LC-II screw and the two LC-II screw group specimens; (P > 0.05); when loads such as 1000 N, 1200 N and 1400 N were applied, there was no significant difference in displacement between the plate fixation group and the two LC-II screw fixation group (P > 0.05), both of which were superior to the one LC-II screw fixation group (P < 0.05). There was no significant difference in compressive stiffness between the two LC-II screw fixation groups and the plate fixation group (P > 0.05), and both were superior to the one LC-II screw fixation group (P < 0.05) the ultimate load of both the two LC-II screws and the steel plate is greater than that of one LC-II screw (1.74 times the ultimate load of one LC-II screw for the two LC-II screws and 1.83 times the ultimate load of one LC-II screw for the steel plate). For posterior pelvic ring fractures of type C1.1, placement of two LC-II screws provides comparable posterior pelvic ring stability compared to reconstructed plates. At loads below 1000 N, one LC-II screw fixation and two LC-II screws were comparable in restoring posterior pelvic ring stability.
- Top Cited PapersOpen Access
- 30 January 2023
- Published by Wiley in Advanced Science
- Vol. 10 (11)
Flourishing Antibacterial Strategies for Osteomyelitis Therapy
Osteomyelitis is a destructive disease of bone tissue caused by infection with pathogenic microorganisms. Because of the complex and long‐term abnormal conditions, osteomyelitis is one of the refractory diseases in orthopedics. Currently, anti‐infective therapy is the primary modality for osteomyelitis therapy in addition to thorough surgical debridement. However, bacterial resistance has gradually reduced the benefits of traditional antibiotics, and the development of advanced antibacterial agents has received growing attention. This review introduces the main targets of antibacterial agents for treating osteomyelitis, including bacterial cell wall, cell membrane, intracellular macromolecules, and bacterial energy metabolism, focuses on their mechanisms, and predicts prospects for clinical applications.
- 30 January 2023
- Published by Wiley in Advanced Science
- Vol. 10 (11)
Top Cited PapersOpen AccessFlourishing Antibacterial Strategies for Osteomyelitis Therapy
Osteomyelitis is a destructive disease of bone tissue caused by infection with pathogenic microorganisms. Because of the complex and long‐term abnormal conditions, osteomyelitis is one of the refractory diseases in orthopedics. Currently, anti‐infective therapy is the primary modality for osteomyelitis therapy in addition to thorough surgical debridement. However, bacterial resistance has gradually reduced the benefits of traditional antibiotics, and the development of advanced antibacterial agents has received growing attention. This review introduces the main targets of antibacterial agents for treating osteomyelitis, including bacterial cell wall, cell membrane, intracellular macromolecules, and bacterial energy metabolism, focuses on their mechanisms, and predicts prospects for clinical applications.
- Open Access
- 1 January 2023
- Published by Acta Physica Sinica, Chinese Physical Society and Institute of Physics, Chinese Academy of Sciences in Acta Physica Sinica
- Vol. 72 (3) , 030201
Abnormal magnetic phenomenon at low temperature in Zn doped \begin{document}$ \left[{(\mathbf{C}\mathbf{H}}_{3}{)}_{2}\mathbf{N}{\mathbf{H}}_{2}\right]{\mathbf{C}\mathbf{o}}_{\mathit{x}}{\mathbf{Z}\mathbf{n}}_{1-\mathit{x}}{\left[\mathbf{H}\mathbf{C}\mathbf{O}\mathbf{O}\right]}_{3} $\end{document} frameworks
金属有机框架材料(MOFs)是一种有机配体桥接金属离子组成的新型无机-有机杂化多孔材料,它具有功能可调、稳定性好以及多孔性等特点, 受到人们的广泛关注.本文利用水热法制备了高质量的锌离子掺杂的钴基[(CH3)2NH2]Co1-xZnx(HCOO3)单晶样品 (x=0, 0.1, 0.2, 0.3, 0.4, 0.5). 单晶衍射、摇摆曲线、EDX的实验结果表明锌离子均匀掺杂进了钴基金属有机框架材料中, 没有出现局部团簇等现象. 低温场冷曲线和比热曲线的测量结果表明, 非磁锌离子的掺杂减弱了Co基MOFs材料中Co离子之间的长程反铁磁相互作用, 使得Co-MOF的反铁磁相变温度由纯钴的15 K变为14.2 K (x=0.1), 12.8 K (x=0.2). 通过对掺锌样品低温下的磁滞回线的细致研究, 我们发现, 掺锌样品 相对于纯钴样品在低温下具有更大的磁滞损耗和矫顽场. 相比于纯钴样品450 Oe的矫顽场, 掺锌样品的矫顽场最高达到3600 Oe, 并且磁滞面积也为纯钴样品的3倍以上. 另一方面, 我们在DMCo0.9Zn0.1F样品的磁滞回线上发现一系列台阶, 这一台阶现象随着温度升高而逐渐消失, 类似于单分子磁体的量子隧穿现象. 以往研究表明, 在这一类钙钛矿结构的金属有机骨架材料中, 存在长程磁相互作用和磁单离子行为的竞争. 我们认为非磁锌离子的掺杂减弱了Co离子之间的长程相互作用, 使得Co离子在低温下显示出量子隧穿引起的台阶效应.
- 1 January 2023
- Published by Acta Physica Sinica, Chinese Physical Society and Institute of Physics, Chinese Academy of Sciences in Acta Physica Sinica
- Vol. 72 (3) , 030201
Open AccessAbnormal magnetic phenomenon at low temperature in Zn doped \begin{document}$ \left[{(\mathbf{C}\mathbf{H}}_{3}{)}_{2}\mathbf{N}{\mathbf{H}}_{2}\right]{\mathbf{C}\mathbf{o}}_{\mathit{x}}{\mathbf{Z}\mathbf{n}}_{1-\mathit{x}}{\left[\mathbf{H}\mathbf{C}\mathbf{O}\mathbf{O}\right]}_{3} $\end{document} frameworks
金属有机框架材料(MOFs)是一种有机配体桥接金属离子组成的新型无机-有机杂化多孔材料,它具有功能可调、稳定性好以及多孔性等特点, 受到人们的广泛关注.本文利用水热法制备了高质量的锌离子掺杂的钴基[(CH3)2NH2]Co1-xZnx(HCOO3)单晶样品 (x=0, 0.1, 0.2, 0.3, 0.4, 0.5). 单晶衍射、摇摆曲线、EDX的实验结果表明锌离子均匀掺杂进了钴基金属有机框架材料中, 没有出现局部团簇等现象. 低温场冷曲线和比热曲线的测量结果表明, 非磁锌离子的掺杂减弱了Co基MOFs材料中Co离子之间的长程反铁磁相互作用, 使得Co-MOF的反铁磁相变温度由纯钴的15 K变为14.2 K (x=0.1), 12.8 K (x=0.2). 通过对掺锌样品低温下的磁滞回线的细致研究, 我们发现, 掺锌样品 相对于纯钴样品在低温下具有更大的磁滞损耗和矫顽场. 相比于纯钴样品450 Oe的矫顽场, 掺锌样品的矫顽场最高达到3600 Oe, 并且磁滞面积也为纯钴样品的3倍以上. 另一方面, 我们在DMCo0.9Zn0.1F样品的磁滞回线上发现一系列台阶, 这一台阶现象随着温度升高而逐渐消失, 类似于单分子磁体的量子隧穿现象. 以往研究表明, 在这一类钙钛矿结构的金属有机骨架材料中, 存在长程磁相互作用和磁单离子行为的竞争. 我们认为非磁锌离子的掺杂减弱了Co离子之间的长程相互作用, 使得Co离子在低温下显示出量子隧穿引起的台阶效应.
- Open Access
- 20 August 2021
- Published by KEAI Publishing in Bioactive Materials
- Vol. 9, 446-460
Biofunctionalized composite scaffold to potentiate osteoconduction, angiogenesis, and favorable metabolic microenvironment for osteonecrosis therapy
Osteonecrosis is a common orthopedic disease in clinic, resulting in joint collapse if no appropriate treatment is performed in time. Core decompression is a general treatment modality for early osteonecrosis. However, effective bone regeneration in the necrotic area is still a significant challenge. This study developed a biofunctionalized composite scaffold (PLGA/nHA30VEGF) for osteonecrosis therapy through potentiation of osteoconduction, angiogenesis, and a favorable metabolic microenvironment. The composite scaffold had a porosity of 87.7% and compressive strength of 8.9 MPa. PLGA/nHA30VEGF had an average pore size of 227.6 μm and a water contact angle of 56.5° with a sustained release profile of vascular endothelial growth factor (VEGF). After the implantation of PLGA/nHA30VEGF, various osteogenic and angiogenic biomarkers were upregulated by 2–9 fold compared with no treatment. Additionally, the metabolomic and lipidomic profiling studies demonstrated that PLGA/nHA30VEGF effectively regulated the multiple metabolites and more than 20 inordinate metabolic pathways in osteonecrosis. The excellent performances reveal that the biofunctionalized composite scaffold provides an advanced adjuvant therapy modality for osteonecrosis.
- 20 August 2021
- Published by KEAI Publishing in Bioactive Materials
- Vol. 9, 446-460
Open AccessBiofunctionalized composite scaffold to potentiate osteoconduction, angiogenesis, and favorable metabolic microenvironment for osteonecrosis therapy
Osteonecrosis is a common orthopedic disease in clinic, resulting in joint collapse if no appropriate treatment is performed in time. Core decompression is a general treatment modality for early osteonecrosis. However, effective bone regeneration in the necrotic area is still a significant challenge. This study developed a biofunctionalized composite scaffold (PLGA/nHA30VEGF) for osteonecrosis therapy through potentiation of osteoconduction, angiogenesis, and a favorable metabolic microenvironment. The composite scaffold had a porosity of 87.7% and compressive strength of 8.9 MPa. PLGA/nHA30VEGF had an average pore size of 227.6 μm and a water contact angle of 56.5° with a sustained release profile of vascular endothelial growth factor (VEGF). After the implantation of PLGA/nHA30VEGF, various osteogenic and angiogenic biomarkers were upregulated by 2–9 fold compared with no treatment. Additionally, the metabolomic and lipidomic profiling studies demonstrated that PLGA/nHA30VEGF effectively regulated the multiple metabolites and more than 20 inordinate metabolic pathways in osteonecrosis. The excellent performances reveal that the biofunctionalized composite scaffold provides an advanced adjuvant therapy modality for osteonecrosis.
- Open Access
- 9 April 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (14) , e25253
Hoffa fracture combined with rotational dislocation of the knee joint
Rationale: Hoffa fracture is a rare fracture confined to the coronal-plane involving femoral condyles. This occurs simultaneously with rotational dislocation of the knee joint is extremely rare. Up to now, there is no valid recommendation for the treatment of the Hoffa fracture. Patient concerns: A 50-year-old female patient broke her knee joint while skiing, experiencing severe pain in the right knee, which was swollen. She presented limited function of the knee and movement upon arrival in the emergency room. Diagnosis: Comminuted Hoffa fracture in the right knee associated with rotational dislocation in the knee joint Interventions: We treated the dislocated knee joint through manual reduction initially. During the operation, we used posterolateral approach to expose the fracture fragments, thereafter using headless compression screws and a buttress plate to provide sufficient stability for the fracture. Early postoperative rehabilitation was encouraged. Outcomes: The patient finally achieved fracture healing three months after operation. In addition, she achieved 0–130° range of function of the knee after four months post-operation, and the patient obtained a satisfactory prognosis after our treatment. Lessons: By using appropriate surgical approach to obtain enough exposure, headless compression screws and the buttress plate provided adequate stability during early active rehabilitation, which resulted in satisfactory results in the treatment of the injury. We reviewed literatures regarding the treatment of Hoffa fracture to demonstrate that our treatment was effective.
- 9 April 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (14) , e25253
Open AccessHoffa fracture combined with rotational dislocation of the knee joint
Rationale: Hoffa fracture is a rare fracture confined to the coronal-plane involving femoral condyles. This occurs simultaneously with rotational dislocation of the knee joint is extremely rare. Up to now, there is no valid recommendation for the treatment of the Hoffa fracture. Patient concerns: A 50-year-old female patient broke her knee joint while skiing, experiencing severe pain in the right knee, which was swollen. She presented limited function of the knee and movement upon arrival in the emergency room. Diagnosis: Comminuted Hoffa fracture in the right knee associated with rotational dislocation in the knee joint Interventions: We treated the dislocated knee joint through manual reduction initially. During the operation, we used posterolateral approach to expose the fracture fragments, thereafter using headless compression screws and a buttress plate to provide sufficient stability for the fracture. Early postoperative rehabilitation was encouraged. Outcomes: The patient finally achieved fracture healing three months after operation. In addition, she achieved 0–130° range of function of the knee after four months post-operation, and the patient obtained a satisfactory prognosis after our treatment. Lessons: By using appropriate surgical approach to obtain enough exposure, headless compression screws and the buttress plate provided adequate stability during early active rehabilitation, which resulted in satisfactory results in the treatment of the injury. We reviewed literatures regarding the treatment of Hoffa fracture to demonstrate that our treatment was effective.